User menu

Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the early diagnosis of asymptomatic bleomycin-induced pneumonitis

Bibliographic reference Connerotte, Thierry ; Lonneux, Max ; de Meeûs, Yves ; Hermans, Cédric ; Vekemans, Marie-Christiane ; et. al. Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the early diagnosis of asymptomatic bleomycin-induced pneumonitis. In: Annals of Hematology, Vol. 87, no. 11, p. 943-945 (2008)
Permanent URL http://hdl.handle.net/2078.1/26831
  1. Martin WG, Ristow KM, Habermann TM, Colgan JP, Witzig TE (2005) Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin’s lymphoma. J Clin Oncol 23:7614–7620
  2. Sleijfer S (2001) Bleomycin-induced pneumonitis. Chest 120:617–624
  3. Hain S, Beggs A (2002) Bleomycin-induced alveolitis detected by FDG positron emission tomography. Clin Nucl Med 27:522–523
  4. Kirsch J, Arrossi AV, Yoon JK, Wu G, Neumann DR (2006) FDG PET/CT features of bleomycin-induced pneumonitis. J Thorac Imaging 21:228–230
  5. von Rohr L, Klaeser B, Joerger M, Kluckert T, Cerny T, Gillessen S (2007) Increased pulmonary FDG uptake in bleomycin-associated pneumonitis. Onkologie 30:320–323
  6. Buchler T, Bomanji J, Lee SM (2007) FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin’s disease—a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica 92:e120–e121
  7. Wilson KS, Worth A, Richards AG, Ford HS (1982) Low-dose bleomycin lung. Med Pediatr Oncol 10:283–288
  8. Canellos GP, Duggan D, Johnson J, Niedzwiecki D (2004) How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen. J Clin Oncol 22:1532–1533
  9. Diederich S, Link ML, Zühlsdorf H, Steinmeyer E, Wormanns D, Heindel W (2001) Pulmonary manifestations of Hodgkin’s disease: radiographic and CT findings. Eur radiol 11:2295–2305
  10. Rigacci L, Vitolo U, Nassi L, Merli F, Gallamini A, Pregno P, Alvarez I, Salvi F, Sancetta R, Castagnoli A, Versari A, Biggi A, Gregianin M, Pelosi E, Chisesi T, Bosi A, Levis A, Intergruppo Italiano Linfomi (2007) Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Ann Hematol 86:897–903
  11. Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, Patti C, Loft A, Di Raimondo F, D’Amore F, Biggi A, Vitolo U, Stelitano C, Sancetta R, Trentin L, Luminari S, Iannitto E, Viviani S, Pierri I, Levis A (2007) Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage hodgkin’s lymphoma: a report from a joint Italian-Danish Study. J Clin Oncol 24:3746–3752